Singapore markets closed

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
0.9650-0.0050 (-0.52%)
At close: 04:56PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
7,041,887
6,907,544
6,603,652
6,993,882
6,358,622
Cost of revenue
4,270,344
4,150,424
4,027,755
4,046,928
3,722,834
Gross profit
2,771,542
2,757,120
2,575,897
2,946,953
2,635,789
Operating expenses
Research development
150,025
161,052
149,202
133,361
100,925
Selling general and administrative
1,637,709
1,645,040
1,541,679
1,914,801
1,760,449
Total operating expenses
2,132,587
2,143,941
1,979,962
2,380,869
2,159,627
Operating income or loss
638,956
613,179
595,934
566,084
476,162
Interest expense
-
2,937
6.66
4,893
11,382
Income before tax
883,062
872,806
768,058
743,145
640,629
Income tax expense
90,821
85,929
88,396
107,786
72,841
Income from continuing operations
792,241
786,877
679,662
635,359
567,788
Net income
775,381
769,144
661,704
625,569
561,680
Net income available to common shareholders
775,381
769,144
661,704
625,569
561,680
Basic EPS
-
1.00
0.86
0.81
0.73
Diluted EPS
-
1.00
0.86
0.81
0.73
Basic average shares
-
769,144
769,424
772,307
769,424
Diluted average shares
-
769,144
769,424
772,307
769,424
EBITDA
-
991,277
878,913
846,187
728,159